The Philadelphia TribuneGene therapy shows promise against blood-clotting diseaseThe Philadelphia TribuneGene therapy has freed 10 men from nearly all symptoms of hemophilia for a year so far, in a study that fuels hopes that a one-time treatment can g… Continue reading
|
Stem Cells Show Durable Benefit For Perianal Fistulas
Gastroenterology & Endoscopy News Orlando, Fla.—In a double-blind, phase 3 trial in patients with Crohn’s disease, stem cell treatment of perianal fistulas provided even better outcomes at 52 weeks than originally reported at 26 weeks. In Europe, where the trial was conducted … |
Medical Xpress |
ASH: CAR T-Cell Tx Offers Durable Response in Pre-Treated MM
MedPage Today ATLANTA – A single infusion of a gene therapy called bb2121 showed promise in heavily pre-treated multiple myeloma patients, offering a complete response that was sustained for beyond a year in some cases, researchers reported here. Of 18 patients … ‘Unheard of’ responses to bluebird CAR–T therapy seen in myeloma studyReuters CAR T, immunotherapy bring new hope for multiple myeloma patientsMedical Xpress #ASH17: The BCMA-targeted CAR–T bb2121 from bluebird and Celgene takes a star turn in the spotlightEndpoints News OncLive –Business Wire (press release) all 23 news articles » |